Showing 1 - 4 results of 4 for search 'N. Maurea', query time: 0.03s Refine Results
  1. 1
    Improved Survival and Quality of Life Through an Integrative, Multidisciplinary Oncological Approach: Pathophysiological Analysis of Four Clinical Cancer Cases and Review of the Literature

    Improved Survival and Quality of Life Through an Integrative, Multidisciplinary Oncological Approach: Pathophysiological Analysis of Four Clinical Cancer Cases and Review of the Li... by M. Berretta, M. Berretta, A. Morra, R. Taibi, F. Monari, N. Maurea, M. Ippolito, U. Tirelli, F. Fiorica, L. Montella, G. Facchini, V. Quagliariello, M. Montopoli, M. Montopoli

    Published 2022-06-01
    Get full text
    Article
  2. 2
    Fasting mimicking diet in mice delays cancer growth and reduces immunotherapy-associated cardiovascular and systemic side effects

    Fasting mimicking diet in mice delays cancer growth and reduces immunotherapy-associated cardiovascular and systemic side effects by S. Cortellino, V. Quagliariello, G. Delfanti, O. Blaževitš, C. Chiodoni, N. Maurea, A. Di Mauro, F. Tatangelo, F. Pisati, A. Shmahala, S. Lazzeri, V. Spagnolo, E. Visco, C. Tripodo, G. Casorati, P. Dellabona, V. D. Longo

    Published 2023-09-01
    Get full text
    Article
  3. 3
    Combinatorial immune checkpoint blockade increases myocardial expression of NLRP-3 and secretion of H-FABP, NT-Pro-BNP, interleukin-1β and interleukin-6: biochemical implications in cardio-immuno-oncology

    Combinatorial immune checkpoint blockade increases myocardial expression of NLRP-3 and secretion of H-FABP, NT-Pro-BNP, interleukin-1β and interleukin-6: biochemical implications i... by V. Quagliariello, M. Passariello, I. Bisceglia, A. Paccone, A. Inno, C. Maurea, R. Rapuano Lembo, L. Manna, M. Iovine, M. L. Canale, M. Scherillo, P. A. Ascierto, D. Gabrielli, C. De Lorenzo, C. De Lorenzo, N. Maurea

    Published 2024-01-01
    Get full text
    Article
  4. 4
    Sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity

    Sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers... by V. Quagliariello, M. L. Canale, I. Bisceglia, M. Iovine, A. Paccone, C. Maurea, M. Scherillo, A. Merola, V. Giordano, G. Palma, A. Luciano, F. Bruzzese, F. Zito Marino, M. Montella, R. Franco, M. Berretta, D. Gabrielli, G. Gallucci, N. Maurea

    Published 2024-05-01
    Get full text
    Article

Search Tools: